Discover 3,601 paid clinical trials in Long Beach, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,601
Active & Responsive
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
for
Recurrent Head and Neck Squamous Cell Carcinoma,
Location: Bellflower CA, Anaheim CA, Los Angeles CA, Ontario CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT04671667
Phase 2, Recruiting
Active & Responsive
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
for
Obesity, Overweight, Diabetes Mellitus, Type 2
Location: Cerritos CA, Pomona CA, Canoga Park CA, La Mesa CA,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07684144
Phase 3, Recruiting
Active & Responsive
Study of DONQ52 in Active Celiac Disease
for
Celiac Disease
Location: Gardena CA, Lancaster CA, Escondido CA, San Diego CA,
Sponsor: Chugai Pharmaceutical
Sex: All
Age: 18 - 70+
Code: NCT07239336
Phase 2, Recruiting
Active & Responsive
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
for
Overweight, Obesity
Location: Rolling Hills Estates CA, Huntington Park CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07589608
Phase 2, Recruiting
Active & Responsive
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
for
Asthma
Location: Rolling Hills Estates CA, Newport Beach CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07219173
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
for
Obesity or Overweight
Location: Chula Vista CA, Santa Ana CA, Rialto CA, San Diego CA,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07575399
Phase 3, Recruiting
Active & Responsive
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
for
Obesity, Overweight
Location: Rolling Hills Estates CA, Huntington Park CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT06143956
Phase 2, Recruiting
Active & Responsive
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
for
Obesity, Overweight
Location: Rolling Hills Estates CA, Fountain Valley CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07321886
Phase 3, Recruiting
Active & Responsive
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
for
Moderate to Severe Chronic Obstructive Pulmonary Disease
Location: La Palma CA, Newport Beach CA, Northridge CA,
Sponsor: Pfizer
Sex: All
Age: 35 - 70+
Code: NCT07363694
Phase 2, Phase 3, Recruiting
Active & Responsive
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
for
Pleuropulmonary Blastoma
Location: Downey CA, Los Angeles CA, Loma Linda CA, Madera CA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT06647953
Phase 3, Recruiting
Active & Responsive
Dose Escalation Study of EG110A, Administered by Intradetrusor Injections to Adults With Neurogenic Detrusor Overactivity-related Incontinence Following Spinal Cord Injury Who Regularly Perform Clean Intermittent Catheterization
Location: Downey CA, Houston TX, Columbus OH, Philadelphia PA
Sponsor: Cyllene Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06596291
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.
for
Spasticity
Location: Downey CA, Dallas TX, Overland Park KS, Elkins Park PA
Sponsor: Ipsen
Sex: All
Age: 18 - 70
Code: NCT04752774
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Huntington Beach CA, Santa Barbara CA, Sacramento CA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 50+
Code: NCT07441642
Phase 2, Recruiting
Active & Responsive
A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear Study)
for
Chronic Hepatitis D Infection
Location: Garden Grove CA
Sponsor: Huahui Health
Sex: All
Age: 12 - 70
Code: NCT07499544
Phase 3, Recruiting
Active & Responsive
Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation
for
Capsular Contracture Associated With Breast Implant,
Location: Huntington Beach CA, Newport Beach CA, Beverly Hills CA,
Sponsor: C. R. Bard
Sex: Female
Age: 22 - 70
Code: NCT05945329
Recruiting
Active & Responsive
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
for
Non-Small Cell Lung Cancer, NSCLC,
Location: Huntington Beach CA, Irvine CA, Duarte CA,
Sponsor: Pierre Fabre Medicament
Sex: All
Age: 18+
Code: NCT06043817
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis
for
Moderate to Severe Psoriatic Arthritis
Location: Huntington Beach CA, San Antonio TX, Colleyville TX,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07801495
Phase 2, Recruiting
Active & Responsive
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)